to address the prescription of lower-cost products) and automatic switches from originator to equivalent drug, etc., which make up the body of rules governing the pharmaceuticals market.Ī singular element of Italian law is the plurality of pharmaceutical policy-making centres the organisation of the SSN implements two levels of governance: the State and the Regions. Regulation of the reimbursement prices of medicines plays a fundamental, although not exclusive role, and within this the sector regulations envisage additional and competing tools of governance, such as: the imposition of expenditure limits (caps) patient co-payment activation of alternative forms of distribution centralised procurement recommendations for prescribing physicians (e.g. Pharmaceutical assistance is one of the spheres of competence of the SSN, so in the constant search for an equilibrium between universalised provision and limited financial resources, market access for pharmaceuticals is fully involved. As with all universalised models, one of the most critical aspects of the SSN is its economic and financial sustainability.
833 of 1978, which draws its inspiration from the principles of universality, equality and equal access to medical care laid out in art. In Italy, the structure of the public healthcare system revolves around the “ Servizio Sanitario Nazionale” (SSN, national health service), a complex articulated group of entities, bodies and functions established with Law no.